You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Phase I, open label, fixed sequence, single centre study in healthy volunteers to investigate the effects of repeated oral doses AZD9668 on the pharmacokinetics and pharmacodynamics of a single dose of warfarin
- Drug Name
- AZD9668
- Generic Name
- AZD9668
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Nov 21, 2010
- Study Name
- D0520C00013
- Study Id
- D0520C00013
- ClinicalTrials.gov ID
- NCT01214122
- Recruiting Status
- Not Yet Recruiting
- Protocol Status
- Not Available
- Report Status
- Not Available
